Clinical Trial Update: MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 single-dose study of MK0633 in Japanese asthmatic children aged 12 to under 16 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK0633

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED